Large-scale testing (Phase 3)Study completedNCT00147758What this trial is testingWelChol® and Sulfonylurea in Treating Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Daiichi Sankyo 400
Large-scale testing (Phase 3)Study completedNCT00960076What this trial is testingAn 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 DiabetesWho this might be right forType 2 Diabetes AstraZeneca 282
Large-scale testing (Phase 3)Study completedNCT02715258What this trial is testingSafety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus Theracos 210
Large-scale testing (Phase 3)Study completedNCT00819091What this trial is testingRandomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea DrugWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 245
Large-scale testing (Phase 3)Study completedNCT06354660What this trial is testingEffect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)Who this might be right forDiabetes Type 2 Eli Lilly and Company 537
Large-scale testing (Phase 3)Study completedNCT01431807What this trial is testingLong-term Study of SYR-472Who this might be right forDiabetes Mellitus Takeda 680
Large-scale testing (Phase 3)Study completedNCT02384941What this trial is testingEfficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin TherapyWho this might be right forType 1 Diabetes Mellitus Lexicon Pharmaceuticals 793
Post-approval studies (Phase 4)Study completedNCT00870194What this trial is testingA Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus MetforminWho this might be right forType 2 Diabetes Mellitus AstraZeneca 255
Large-scale testing (Phase 3)Study completedNCT00103857What this trial is testingMK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 1,208
Large-scale testing (Phase 3)Study completedNCT02419612What this trial is testingA 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneWho this might be right forDiabetes AstraZeneca 444
Large-scale testing (Phase 3)Study completedNCT01042977What this trial is testingEfficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseWho this might be right forType 2 Diabetes MellitusCardiovascular DiseaseInadequate Glycaemic Control AstraZeneca 964
Large-scale testing (Phase 3)Study completedNCT01242228What this trial is testingAssess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic PatientsWho this might be right forType 2 Diabetes Mellitus Astellas Pharma Inc 106
Post-approval studies (Phase 4)Study completedNCT02808351What this trial is testingBerberine Prevent Contrast-induced Nephropathy in Patients With DiabetesWho this might be right forDiabetes MellitusChronic Kidney Disease Nanjing First Hospital, Nanjing Medical University 800
Not applicableWithdrawnNCT06692153What this trial is testingEmbecta AID System in Adults With Type 2 DiabetesWho this might be right forType 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 DM+4 more Embecta Corp.
Large-scale testing (Phase 3)Study completedNCT00813995What this trial is testingTest the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 395
Large-scale testing (Phase 3)Study completedNCT00854035What this trial is testingMK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus Ono Pharmaceutical Co., Ltd. 266
Large-scale testing (Phase 3)Study completedNCT00621140What this trial is testingEfficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic ControlWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 503
Large-scale testing (Phase 3)Study completedNCT01809327What this trial is testingEvaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and ExerciseWho this might be right forDiabetes Mellitus, Type 2 Janssen Research & Development, LLC 1,186
Testing effectiveness (Phase 2)Study completedNCT01340664What this trial is testingAn Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin MonotherapyWho this might be right forDiabetes Mellitus, Type 2 Janssen Research & Development, LLC 279
Post-approval studies (Phase 4)Study completedNCT02025907What this trial is testingEvaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and SitagliptinWho this might be right forDiabetes Mellitus, Type 2 Janssen Research & Development, LLC 218